comparemela.com

Latest Breaking News On - Cardiol therapeutics - Page 2 : comparemela.com

Cardiol Therapeutics (NASDAQ:CRDL) Given New $8.00 Price Target at Canaccord Genuity Group

Cardiol Therapeutics (NASDAQ:CRDL – Get Free Report) had its price target increased by research analysts at Canaccord Genuity Group from $6.00 to $8.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The firm presently has a “buy” rating on the stock. Canaccord Genuity Group’s price objective would suggest a potential […]

Nasdaq
Canaccord-genuity-group
Cardiol-therapeutics-inc
Exchange-commission
Tejara-capital-ltd
Cardiol-therapeutics
Get-free-report
Genuity-group
Therapeutics-trading-down
Capital-ltd
Free-report

Cardiol Therapeutics Inc. (NASDAQ:CRDL) Short Interest Up 19.2% in April

Cardiol Therapeutics Inc. (NASDAQ:CRDL – Get Free Report) was the recipient of a significant growth in short interest in April. As of April 30th, there was short interest totalling 328,100 shares, a growth of 19.2% from the April 15th total of 275,200 shares. Based on an average daily volume of 391,900 shares, the days-to-cover ratio […]

Cardiol-therapeutics-inc
Exchange-commission
Nasdaq
Laird-norton-trust-company
Cardiol-therapeutics
Get-free-report
Norton-trust-company
Free-report
Therapeutics-inc
Cardiol-therapeutics-daily

CRDL Stock Earnings: Cardiol Therapeutics Meets EPS for Q1 2024

CRDL Stock Earnings: Cardiol Therapeutics Meets EPS for Q1 2024
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Cardiol-therapeutics
Place-earnings

Cardiol Therapeutics Inc.: Cardiol Therapeutics Announces Phase II ARCHER Trial Presented at the World Congress on Acute Heart Failure 2024

Cardiol Therapeutics Inc.: Cardiol Therapeutics Announces Phase II ARCHER Trial Presented at the World Congress on Acute Heart Failure 2024
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Israel
Lisbon
Lisboa
Portugal
Toronto
Ontario
Canada
France
United-states
Brazil
Berlin
Germany

Cardiol Therapeutics surpasses 85% enrollment in ARCHER trial for acute myocarditis

Cardiol Therapeutics surpasses 85% enrollment in ARCHER trial for acute myocarditis
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

United-states
Berlin
Germany
David-elsley
Carsten-tsch
Berlin-institute-of-health
Nasdaq
World-congress-on-acute-heart-failure
Cardiol-therapeutics
World-congress
Acute-heart-failure
Berlin-institute
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.